Related Experiment Videos
Conjugated catecholamines in human plasma: where are they coming from?
J L Cuche1, P Brochier, N Klioua
1Clinical Pharmacology Laboratory, Faculty of Medicine, Paris, France.
The Journal of Laboratory and Clinical Medicine
|November 1, 1990
Summary
The sympathetic nervous system does not significantly impact conjugated catecholamine levels in human plasma. This study found no correlation between sympathetic activity and these crucial hormone metabolites.
Area of Science:
- Biochemistry
- Neuroendocrinology
- Physiology
Background:
- The origins of conjugated catecholamines are not well understood.
- This study investigates the potential role of the sympathetic nervous system in their production.
Purpose of the Study:
- To determine if sympathetic nervous system activity influences plasma levels of conjugated catecholamines.
- To explore the relationship between sympathetic activity, catecholamine release/uptake, and conjugated catecholamine concentrations.
Main Methods:
- Measured plasma sulfoconjugated and glucuroconjugated catecholamines in patients undergoing electroconvulsive therapy.
- Assessed plasma catecholamine and conjugated catecholamine levels in volunteers during insulin-induced hypoglycemia.
Main Results:
- Electroconvulsive therapy transiently increased blood pressure and plasma norepinephrine/epinephrine but did not alter conjugated catecholamine levels.
- Insulin-induced hypoglycemia significantly increased plasma norepinephrine/epinephrine, while sulfoconjugates decreased and glucuroconjugates increased slightly.
- No significant correlation was observed between sympathetic nervous system activation and plasma conjugated catecholamine levels.
Conclusions:
- Sympathetic nervous system activity does not appear to be a major determinant of circulating conjugated catecholamine levels in humans.
- Existing evidence suggests the intestinal wall and renal function are more critical for regulating plasma sulfoconjugated catecholamines.